This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Fasciculation
R18_FASCICULATION
persistent fetal circulation syndrome: A syndrome of persistent PULMONARY HYPERTENSION in the newborn infant (INFANT, NEWBORN) without demonstrable HEART DISEASES. This neonatal condition can be caused by severe pulmonary vasoconstriction (reactive type), hypertrophy of pulmonary arterial muscle (hypertrophic type), or abnormally developed pulmonary arterioles (hypoplastic type). The newborn patient exhibits CYANOSIS and ACIDOSIS due to the persistence of fetal circulatory pattern of right-to-left shunting of blood through a patent ductus arteriosus (DUCTUS ARTERIOSUS, PATENT) and at times a patent foramen ovale (FORAMEN OVALE, PATENT).
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
495 |
4. Check minimum number of eventsNone |
495 |
5. Include endpointsNone |
495 |
6. Filter based on genotype QC (FinnGen only) |
456 |
Control definitions (FinnGen only)
- Control exclude
- CD2_BENIGN_FEMALE_GEN_OTH
Extra metadata
- Level in the ICD hierarchy
- 4
- Special
- FASCICULATION
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- R25
- Name in latin
- Fasciculationes
Similar endpoints
↥List of similar endpoints to
Fasciculation
based on the number of shared cases.
Similar with more cases:
- Abnormal involuntary movements
- Symptoms and signs involving the nervous and musculoskeletal systems
- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
- Any prescribed medicine buy
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 456 | 252 | 204 |
| Unadjusted period prevalence (%) | 0.09 | 0.09 | 0.09 |
| Median age at first event (years) | 49.26 | 44.72 | 54.87 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 467
- Matched controls
- 4670
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
R25.3
ICD-10 Finland
Fasciculation
+∞
307.7
467
*
N03AE01
ATC
clonazepam; systemic
8.8
61.9
86
117
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
6.2
52.4
105
210
R25.2
ICD-10 Finland
Cramp and spasm
11.1
45.9
51
51
TAB00
NOMESCO Finland
Lumbar puncture
5.7
28.9
58
114
L19
ICPC
Muscle symptom/complaint NOS
8.8
28.6
37
45
R20.2
ICD-10 Finland
Paraesthesia of skin
4.4
27.3
76
197
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
5.1
25.0
57
125
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
4.4
22.1
59
147
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
3.1
20.6
100
373
G12.2
ICD-10 Finland
Motor neuron disease
37.6
20.0
25
7
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.5
19.9
219
1233
N04BC05
ATC
pramipexole; oral
4.0
19.6
59
161
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.1
16.6
77
278
A02BC05
ATC
esomeprazole; systemic
2.2
16.2
222
1342
H53.1
ICD-10 Finland
Subjective visual disturbances
3.5
15.7
59
187
R25.1
ICD-10 Finland
Tremor, unspecified
6.0
15.6
28
49
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
5.5
14.6
29
56
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
5.6
14.4
28
53
Z01.8
ICD-10 Finland
Other specified special examinations
2.3
13.9
130
664
A02BC02
ATC
pantoprazole; systemic
2.2
13.6
337
2507
R07.4
ICD-10 Finland
Chest pain, unspecified
2.2
13.4
152
838
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.2
13.3
144
779
N03AX16
ATC
[U] pregabalin
2.3
12.4
123
639
R42
ICD-10 Finland
Dizziness and giddiness
2.3
12.4
119
610
D06
ICPC
Abdominal pain localized other
2.9
12.0
61
231
R25.8
ICD-10 Finland
Other and unspecified abnormal involuntary movements
48.0
11.9
14
*
H93.1
ICD-10 Finland
Tinnitus
3.1
11.8
52
181
K04
ICPC
Palpitations/awareness of heart
3.3
10.4
40
128
N03AX12
ATC
[U] gabapentin; oral
2.3
10.3
93
463
R53
ICD-10 Finland
Malaise and fatigue
2.0
10.2
141
826
Z71.8
ICD-10 Finland
Other specified counselling
1.9
10.2
187
1207
R51.80
ICD-10 Finland
Headache
2.2
10.1
104
544
R00.2
ICD-10 Finland
Palpitations
2.7
10.0
56
222
K30
ICD-10 Finland
Functional dyspepsia
2.5
9.9
69
305
K80
ICPC
Cardiac arrhythmia NOS
2.8
9.8
53
207
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.9
9.7
160
993
N02BF01
ATC
gabapentin; oral
2.5
9.6
64
277
UKC02
NOMESCO Finland
Cystoscopy
2.3
9.5
78
371
R00.0
ICD-10 Finland
Tachycardia, unspecified
3.4
9.5
34
104
M79.1
ICD-10 Finland
Myalgia
2.2
9.5
92
470
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.9
9.2
139
834
M03BX01
ATC
baclofen; systemic
4.9
9.1
20
42
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.8
9.0
192
1286
R21
ICPC
Throat symptom/complaint
2.0
9.0
127
744
N05BA04
ATC
oxazepam; oral
1.9
9.0
136
817
H04.10
ICD-10 Finland
Dry eye syndrome
2.4
8.9
68
314
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.4
8.8
64
288
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.0
8.8
105
579
R07.0
ICD-10 Finland
Pain in throat
2.8
8.6
45
173
G51.4
ICD-10 Finland
Facial myokymia
20.5
8.5
12
6
D01
ICPC
Abdominal pain/cramps general
2.3
8.5
72
347
XA402
NOMESCO Finland
ENMG
4.5
8.2
20
46
M79.6
ICD-10 Finland
Pain in limb
1.8
8.2
219
1558
H02AB06
ATC
prednisolone; systemic
1.8
8.2
223
1596
G25.3
ICD-10 Finland
Myoclonus
34.0
8.1
10
*
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
2.5
8.0
52
222
J01MA02
ATC
ciprofloxacin; systemic
1.8
8.0
176
1182
S29
ICPC
Skin symptom/complaint other
2.0
8.0
103
583
R02
ICPC
Shortness of breath/dyspnoea
2.2
7.9
70
344
N02BF02
ATC
pregabalin; oral
2.8
7.9
41
157
R96
ICPC
Asthma
2.4
7.8
53
232
N99
ICPC
Neurological disease other
12.1
7.6
13
11
R03DC03
ATC
montelukast; oral
2.0
7.6
88
479
Z3231
NOMESCO Finland
Registered nurse
1.8
7.6
130
808
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.1
7.5
73
371
F45.8
ICD-10 Finland
Other somatoform disorders
2.5
7.4
47
199
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.0
7.3
92
516
R03BA02
ATC
budesonide; inhalant
2.0
7.2
94
532
I49.3
ICD-10 Finland
Ventricular premature depolarization
2.6
7.2
43
176
R12
ICD-10 Finland
Heartburn
2.4
7.2
52
234
R13
ICD-10 Finland
Dysphagia
2.6
7.1
42
172
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
3.0
7.0
31
108
A02BC01
ATC
omeprazole; systemic
1.8
7.0
127
801
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.2
6.9
60
292
SHB00
NOMESCO Finland
Preparing and fitting the occlusal splint in the mouth
2.1
6.9
66
334
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
2.0
6.9
79
428
L17
ICPC
Foot/toe symptom/complaint
1.7
6.8
145
957
K21
ICD-10 Finland
Gastro-oesophageal reflux disease
2.6
6.7
39
158
N06AX11
ATC
mirtazapine; oral
1.7
6.7
164
1125
U02
ICPC
Urinary frequency/urgency
2.1
6.6
71
375
R06.0
ICD-10 Finland
Dyspnoea
1.8
6.6
129
829
XF404
NOMESCO Finland
Ambulatory ECG
2.5
6.6
42
178
Z71.9
ICD-10 Finland
Counselling, unspecified
2.4
6.6
48
217
Z3226
NOMESCO Finland
Physiotherapist
1.9
6.5
86
488
D03
ICPC
Heartburn
3.0
6.5
28
96
R03AC02
ATC
salbutamol; inhalant
1.7
6.5
264
2057
A01
ICPC
Pain general/multiple sites
2.3
6.5
53
251
N06AX16
ATC
venlafaxine; oral
2.0
6.5
81
452
C07AA05
ATC
propranolol; systemic
1.8
6.4
108
663
JDB10
NOMESCO Finland
Percutaneous gastrostomy
8.3
6.4
13
16
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
3.4
6.4
23
71
XKD00
NOMESCO Finland
Uroflowmetry
2.0
6.3
67
353
D22
ICD-10 Finland
Melanocytic naevi
2.6
6.3
36
145
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.0
6.3
73
397
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.0
6.2
71
384
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
6.2
206
1522
X14
ICPC
Vaginal discharge
4.2
6.1
16
39
N17
ICPC
Vertigo/dizziness
2.1
6.1
59
299
Z01.7
ICD-10 Finland
Laboratory examination
1.9
6.1
86
499
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.6
6.1
263
2068
N05AH04
ATC
quetiapine; oral
1.8
6.1
97
586
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
283
1182
4.54
57.25
2.6
2.1
140.07
243.94
u/l
1.16
268
1126
167
652
3.43
33.52
2.5
3.4
0.83
0.82
mmol/l
0.68
150
622
37
39
10.22
31.90
1.0
1.1
—
—
—
0
0
105
321
3.93
30.26
2.7
2.3
21.34
14.36
au/ml
—
10
31
35
40
9.38
28.39
1.0
1.1
—
—
—
0
0
29
28
10.98
26.48
1.1
1.1
26.41
41.34
mg/l
0.54
22
22
30
37
8.60
22.88
1.0
1.1
—
—
—
0
0
46
91
5.50
22.62
1.3
1.2
3.64
3.70
mmol/l
0.19
40
85
295
1886
2.53
20.46
8.4
7.2
1.22
1.21
mmol/l
0.51
264
1649
43
90
5.16
19.82
1.4
1.4
521.08
101.20
e6/l
0.38
38
71
42
89
5.09
19.08
1.4
1.2
1.40
18.16
e6/l
0.92
35
67
335
2352
2.50
17.74
8.8
9.6
3.62
4.07
e9/l
4.18
305
2059
263
1675
2.31
17.26
4.5
5.0
37.89
36.47
g/l
4.74
252
1596
29
23
13.36
16.87
1.0
1.0
—
—
—
0
0
221
1333
2.25
16.24
2.9
3.2
2.35
2.35
mmol/l
0.20
210
1233
262
1701
2.23
15.96
7.6
6.5
1.21
1.21
mmol/l
0.15
242
1584
391
3040
2.76
15.26
5.6
4.2
8.29
10.37
mm/h
3.77
380
2861
120
589
2.40
14.02
2.3
2.3
82.66
107.52
ug/g
0.58
100
471
140
738
2.28
13.85
2.8
2.6
2.42
2.44
mmol/l
1.12
131
662
397
3189
2.63
13.04
5.5
4.3
14.66
14.57
pmol/l
0.32
383
2964
385
3068
2.45
12.54
8.8
8.2
69.87
76.33
u/l
5.14
375
2926
22
21
10.93
11.88
1.3
1.2
0.47
0.48
ratio
0.18
14
12
246
1680
1.98
11.77
2.1
2.0
104.22
96.02
pmol/l
1.78
124
910
177
1115
1.95
10.40
1.4
1.3
3.05
1.97
u/ml
0.25
54
324
18
17
10.96
9.86
1.0
1.1
0.98
1.19
u/l
—
8
7
39
128
3.23
9.76
1.6
2.0
145.31
262.60
ug/l
0.90
33
122
172
1097
1.90
9.57
1.5
1.6
20.08
20.60
nmol/l
0.20
152
953
194
1289
1.86
9.48
2.5
2.5
59.41
63.88
u/l
0.40
185
1221
127
733
2.01
9.47
4.1
3.8
64.15
378.67
ng/l
2.80
80
515
66
293
2.46
9.40
2.0
2.8
69.40
67.34
g/l
1.64
58
280
280
2091
1.85
9.32
3.5
3.1
118.99
118.80
ug/l
0.00
272
1986
431
3773
2.85
8.93
6.9
5.2
1.74
1.85
mu/l
1.90
417
3546
278
2120
1.77
8.15
5.9
6.7
10.82
11.11
umol/l
0.19
264
2034
148
958
1.80
7.53
2.3
1.7
0.91
1.23
mg/l
1.06
111
743
295
2318
1.74
7.49
6.4
5.0
6.31
6.58
mmol/l
1.89
286
2176
164
1101
1.75
7.33
4.7
2.9
0.08
0.36
e6/l
6.00
129
798
124
771
1.83
7.16
1.6
1.7
440.20
28571859.43
pmol/l
0.77
110
665
153
1016
1.75
7.06
2.2
2.1
2.24
2.70
mg/l
3.57
128
894
112
680
1.85
6.96
3.3
2.8
0.41
0.86
e6/l
3.52
67
348
239
1807
1.66
6.71
2.7
2.5
74.57
74.60
nmol/l
0.00
231
1663
135
879
1.75
6.61
3.9
2.5
4.15
6.17
e6/l
1.05
122
802
73
391
2.03
6.55
2.3
2.5
31.51
30.75
u/l
0.15
67
330
104
634
1.82
6.33
3.5
2.9
2.47
1.94
e6/l
0.22
59
302
428
3850
2.34
6.28
5.2
4.7
5.74
5.86
mmol/l
1.45
414
3595
443
4051
2.82
6.20
19.0
14.2
19.08
22.37
mg/l
1.56
370
3297
77
434
1.93
5.96
1.9
2.1
390.99
376.38
nmol/l
0.23
72
408
48
227
2.24
5.91
2.6
2.7
80.10
162.17
ng/l
2.37
40
204
72
400
1.95
5.81
2.0
2.2
—
—
—
0
0
130
866
1.69
5.76
1.4
1.3
58.87
28.06
iu/ml
0.31
30
266
51
250
2.17
5.76
1.1
1.0
—
—
—
0
0
274
2202
1.59
5.59
4.5
3.5
0.00
3.33
estimate
0.50
59
452
200
1494
1.59
5.58
3.4
3.3
30.08
32.38
u/l
0.69
192
1424
81
479
1.84
5.39
1.7
2.9
4.93
6.75
umol/l
1.65
69
425
271
2188
1.57
5.29
4.6
3.4
0.00
0.00
estimate
-0.00
58
452
274
2229
1.55
5.09
4.5
3.5
0.00
0.73
estimate
0.51
54
422
112
740
1.68
5.05
1.6
1.5
—
—
—
0
0
69
398
1.86
4.96
6.7
9.3
12.19
12.41
kpa
0.14
64
387
69
398
1.86
4.96
6.7
9.3
5.41
5.08
kpa
1.65
64
385
59
326
1.93
4.83
1.5
1.5
—
—
—
0
0
193
1466
1.54
4.82
3.6
3.5
30.88
76.92
ng/l
0.56
109
962
100
650
1.69
4.78
2.2
2.5
16.47
14.00
umol/l
1.46
89
608
31
134
2.41
4.70
1.5
1.3
—
—
—
0
0
117
795
1.63
4.70
1.3
1.3
1.60
7.16
u/ml
3.72
53
308
36
167
2.25
4.66
1.8
1.7
78.96
9.36
u/ml
—
9
36
58
323
1.91
4.64
1.7
2.1
—
—
—
0
0
82
510
1.74
4.59
4.9
6.4
1.03
1.04
mmol/l
0.06
74
479
67
395
1.81
4.49
6.8
9.4
1.84
0.61
mmol/l
1.64
56
332
144
1043
1.55
4.38
2.8
3.2
589.51
1026.00
ng/l
1.87
116
872
73
451
1.73
4.17
1.8
1.8
—
—
—
0
0
27
117
2.39
4.09
2.4
2.5
—
—
—
0
0
410
3767
1.72
3.68
6.0
5.9
37.82
38.67
mmol/mol
1.29
397
3584
39
206
1.97
3.66
3.4
3.3
2.53
1.41
mmol/l
0.75
29
153
132
971
1.50
3.65
3.5
3.4
1.02
1.02
kg/l
0.19
86
656
46
258
1.87
3.62
2.0
1.6
—
—
—
0
0
129
948
1.50
3.58
2.0
1.7
—
—
—
0
0
30
145
2.14
3.56
1.3
1.3
—
2.52
—
0
5
49
283
1.82
3.52
3.3
3.8
4.46
4.62
pmol/l
0.67
42
256
20
81
2.53
3.51
1.2
1.1
37.55
14.27
au/ml
—
6
32
326
2861
1.46
3.46
3.6
3.4
—
—
—
0
0
207
1675
1.42
3.44
4.3
3.3
0.15
0.02
estimate
0.81
55
392
30
149
2.08
3.33
2.3
1.7
0.22
0.23
g/l
0.45
30
143
98
689
1.53
3.33
2.4
2.2
—
—
—
0
0
10
23
4.42
3.32
1.1
1.0
1335.30
1656.22
miu/ml
—
10
23
56
345
1.71
3.24
11.8
4.0
2.00
1.58
mmol/l
0.38
50
292
66
427
1.64
3.18
1.9
1.9
—
—
—
0
0
62
397
1.65
3.11
2.9
2.4
11.57
13.21
nmol/l
0.86
57
370
30
154
2.01
3.07
2.2
1.6
1.18
1.18
g/l
0.03
30
147
6
8
7.58
3.06
1.0
1.5
—
—
—
0
0
417
3888
1.68
3.03
17.9
13.5
85.71
86.11
ml/min/173m2
0.15
395
3582
90
636
1.51
2.97
2.0
2.1
—
—
—
0
0
24
115
2.15
2.94
1.3
1.3
—
—
—
0
0
83
578
1.53
2.93
1.6
1.6
1061.28
1192.41
nmol/l
0.74
65
454
458
4435
2.70
2.89
29.2
21.7
249.86
252.70
e9/l
0.47
453
4365
86
606
1.51
2.88
2.3
2.5
2.42
2.35
g/l
0.58
80
563
24
116
2.13
2.88
1.4
2.2
0.00
0.00
g/l
-0.00
24
111
24
116
2.13
2.88
1.6
1.4
321.29
303.61
ug/g
0.16
15
66
36
205
1.82
2.74
2.4
2.0
6.13
7.28
iu/ml
—
8
50
79
556
1.51
2.66
2.4
2.5
26.32
24.04
%
0.89
73
528
30
163
1.90
2.64
2.0
1.7
—
—
—
0
0
150
1195
1.38
2.58
4.9
3.6
0.00
0.01
estimate
0.96
58
427
209
1754
1.35
2.57
2.0
1.9
1.40
1.38
mmol/l
0.07
187
1517
15
62
2.47
2.56
1.0
1.1
—
—
—
0
0
5
7
7.21
2.55
1.0
1.3
—
—
—
0
0
5
7
7.21
2.55
1.0
1.1
—
—
—
0
0
6
11
5.51
2.55
1.0
1.3
—
—
—
0
0
30
167
1.85
2.47
1.5
1.3
9.97
9.87
u/l
0.01
23
138
12
45
2.71
2.47
1.3
1.3
—
—
—
0
0
52
339
1.60
2.46
1.4
1.2
109.70
148.10
u/ml
0.39
24
139
425
4019
1.64
2.45
5.2
4.8
1.44
1.45
mmol/l
0.03
404
3780
22
111
2.03
2.39
1.3
2.2
0.00
0.00
g/l
-0.00
22
102
5
8
6.30
2.37
1.0
1.3
—
—
—
0
0
5
8
6.30
2.37
1.0
1.4
—
—
—
0
0
7
17
4.16
2.37
1.7
2.0
167.40
130.42
ng/l
—
7
17
43
270
1.65
2.36
3.2
4.3
73.57
87.58
ng/l
0.80
38
245
20
99
2.07
2.29
1.4
1.3
226.31
231.90
u/ml
0.04
13
52
7
18
3.93
2.26
1.0
1.3
—
—
—
0
0
36
219
1.70
2.23
1.4
1.6
0.39
0.31
mg/l
—
10
98
428
4071
1.61
2.19
6.0
5.4
2.76
2.75
mmol/l
0.06
411
3842
84
624
1.42
2.15
1.9
1.9
—
—
—
0
0
21
109
1.97
2.14
1.3
1.3
—
11.89
—
0
7
23
124
1.90
2.11
1.3
1.3
—
—
—
0
0
16
75
2.17
2.11
1.4
1.2
—
—
—
0
0
23
125
1.88
2.06
2.8
2.2
3.71
5.20
iu/l
0.58
12
53
423
4026
1.54
1.99
5.3
4.9
4.67
4.66
mmol/l
0.07
405
3810
42
276
1.57
1.95
1.5
1.3
26.27
23.25
iu/l
0.20
32
233
5
11
4.58
1.94
1.2
2.4
134.60
135.73
%
—
5
11
7
22
3.21
1.88
1.0
1.1
—
—
—
0
0
9
34
2.68
1.87
1.4
1.5
—
—
—
0
0
6
17
3.56
1.84
1.0
2.8
172.33
211.18
u/l
—
6
17
48
330
1.51
1.84
5.9
7.9
8.66
9.15
mmol/l
0.17
43
320
5
12
4.20
1.82
2.0
1.0
—
—
—
0
0
7
23
3.07
1.80
1.1
1.3
—
—
—
0
0
7
23
3.07
1.80
1.1
1.3
—
—
—
0
0
35
225
1.60
1.79
1.6
1.3
—
—
—
0
0
58
417
1.45
1.78
6.9
6.3
—
—
—
0
0
151
1262
1.29
1.78
5.9
5.1
1.79
2.26
ug/l
0.73
144
1149
27
163
1.70
1.75
1.3
1.6
—
—
—
0
0
325
2991
1.28
1.71
3.6
3.3
38.49
44.19
u/l
1.05
309
2875
15
75
2.03
1.71
1.4
1.2
—
288.00
—
0
5
79
608
1.36
1.65
1.6
1.9
1.46
1.40
%
0.69
73
547
19
105
1.84
1.65
1.4
3.6
1.80
2.03
ratio
—
10
59
150
1268
1.27
1.60
4.0
2.9
0.04
0.08
estimate
0.26
54
377
7
26
2.72
1.58
1.6
1.2
—
—
—
0
0
122
1007
1.29
1.57
4.5
4.3
21.85
21.90
%
0.01
54
453
8
33
2.45
1.54
1.6
1.2
165.00
180.22
pmol/l
—
8
33
5
15
3.36
1.52
1.0
1.0
—
—
—
0
0
14
72
1.97
1.50
1.3
1.5
—
—
—
0
0
5
16
3.15
1.44
2.4
6.0
—
—
—
0
0
6
22
2.75
1.44
1.2
1.2
316.38
129.08
iu/ml
—
6
22
10
46
2.20
1.41
1.3
1.3
—
—
—
0
0
19
112
1.73
1.37
1.1
1.2
0.31
2.33
u/ml
—
10
62
6
23
2.63
1.37
4.5
3.9
76.50
152.70
nmol/l
—
6
23
18
105
1.74
1.35
2.7
2.9
0.78
1.99
index
—
9
63
401
3834
1.32
1.32
4.4
4.1
1.34
1.29
mmol/l
0.48
380
3586
156
1354
1.23
1.28
3.4
3.4
8.02
8.09
mmol/l
0.06
139
1177
26
171
1.55
1.26
1.5
1.4
—
—
—
0
0
22
142
1.58
1.16
1.4
1.6
0.00
0.05
iu/ml
—
8
25
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
5
20
2.52
1.15
1.2
1.1
100.80
124.95
%
—
5
20
5
20
2.52
1.15
1.0
2.2
1.80
0.95
nmol/l
—
5
14
92
762
1.26
1.15
3.2
3.0
0.67
0.74
ug/l
0.26
62
461
39
285
1.40
1.15
2.2
2.3
4.41
6.58
ug/l
0.94
34
256
33
234
1.44
1.14
2.2
2.1
181.12
5246.55
u/l
2.39
13
101
8
40
2.02
1.12
1.8
1.7
—
—
—
0
0
39
287
1.39
1.11
5.1
3.7
1.23
1.22
mmol/l
0.27
33
255
68
548
1.28
1.07
2.2
1.9
3.48
3.51
ratio
0.07
56
444
7
33
2.14
1.06
1.4
1.4
—
—
—
0
0
12
69
1.76
0.97
2.3
2.0
6.11
5.37
mmol/24h
0.31
12
63
28
203
1.40
0.89
1.6
1.5
—
—
—
0
0
16
103
1.57
0.88
1.4
1.2
—
—
—
0
0
8
43
1.88
0.87
1.0
1.2
—
—
—
0
0
6
30
2.01
0.87
1.3
1.1
—
—
—
0
0
12
72
1.68
0.86
1.1
1.4
—
—
—
0
0
12
72
1.68
0.86
1.1
1.4
—
—
—
0
0
17
113
1.52
0.83
1.4
1.2
—
—
—
0
0
37
472
0.77
0.81
4.8
4.6
30.33
31.28
%
0.17
24
318
8
47
1.71
0.81
1.3
1.2
—
—
—
0
0
8
47
1.71
0.81
1.3
1.2
—
—
—
0
0
6
33
1.83
0.79
1.0
1.1
107.83
108.03
pmol/l
—
6
33
14
90
1.57
0.79
1.1
1.1
1.24
2.10
eliau/ml
—
7
40
39
306
1.30
0.78
2.1
2.3
70.72
70.99
ml/min/173m2
0.02
18
140
20
141
1.44
0.76
1.4
1.6
—
—
—
0
0
209
1936
1.14
0.74
2.8
2.8
—
—
estimate
—
0
0
12
76
1.59
0.72
1.8
1.1
98.00
95.44
iu/ml
—
5
18
46
374
1.26
0.71
2.5
3.0
—
—
—
0
0
25
187
1.36
0.69
1.6
1.9
2.67
2.80
mg/l
0.08
17
138
27
206
1.33
0.67
19.9
2.4
0.59
0.62
%
0.22
27
206
7
43
1.64
0.67
1.0
1.0
—
—
—
0
0
8
49
1.64
0.62
1.3
1.2
—
—
—
0
0
8
49
1.64
0.62
1.3
1.2
—
—
—
0
0
16
113
1.43
0.62
1.3
1.2
—
—
—
0
0
5
30
1.67
0.61
1.2
1.3
—
—
—
0
0
28
219
1.30
0.60
2.1
1.7
—
—
—
0
0
22
167
1.33
0.58
1.5
1.4
—
—
—
0
0
8
54
1.49
0.57
1.3
1.1
—
—
—
0
0
24
185
1.31
0.57
1.3
1.4
375.37
256.52
miu/ml
0.44
11
90
49
413
1.21
0.57
1.7
1.7
3.47
3.47
mmol/l
0.00
33
312
37
304
1.24
0.55
1.5
1.5
1000.52
971.65
mu/l
0.09
31
256
14
99
1.43
0.54
1.8
1.7
—
—
—
0
0
9
62
1.46
0.53
1.2
1.0
—
—
—
0
0
6
40
1.51
0.51
6.2
4.2
—
—
—
0
0
19
144
1.33
0.51
14.6
2.4
3.18
3.48
g/l
0.65
19
139
11
77
1.44
0.46
1.5
3.4
—
4640.83
u/ml
—
0
6
113
1037
1.12
0.45
3.2
2.8
328.43
339.67
umol/l
0.49
101
942
7
51
1.38
0.44
1.4
1.8
—
—
—
0
0
21
166
1.28
0.44
1.5
1.5
1.25
1.15
ratio
0.13
11
104
21
166
1.28
0.44
1.5
1.5
1.30
1.30
ratio
0.00
11
104
21
166
1.28
0.44
1.5
1.5
1.02
0.96
ratio
0.33
11
104
5
31
1.62
0.43
1.0
1.2
3.40
9.39
mm/h
—
5
31
6
94
0.63
0.42
1.5
1.5
1.48
0.92
nmol/l
—
6
84
8
58
1.39
0.41
1.3
1.2
—
—
—
0
0
5
33
1.52
0.41
1.0
1.5
—
—
—
0
0
8
59
1.36
0.41
5.8
1.9
13.38
13.10
%
—
8
59
5
34
1.48
0.40
1.4
1.6
—
—
—
0
0
5
34
1.48
0.40
22.2
12.1
0.47
0.62
mmol/l
—
5
34
5
35
1.43
0.39
1.2
1.1
—
—
—
0
0
5
35
1.43
0.39
6.2
2.3
—
—
—
0
0
0
19
0.00
0.39
0.0
1.6
—
—
—
0
0
5
77
0.65
0.36
1.0
1.1
—
—
—
0
0
132
1238
1.09
0.35
3.9
4.1
8.93
10.36
mg/mmol
0.12
84
786
20
164
1.23
0.33
1.6
1.5
—
—
—
0
0
6
46
1.31
0.33
1.5
1.9
—
—
—
0
0
16
128
1.26
0.32
1.7
1.8
—
—
—
0
0
15
185
0.80
0.30
1.2
1.1
1.58
1.54
g/l
0.24
15
185
12
152
0.78
0.30
1.4
2.0
—
—
—
0
0
24
204
1.19
0.29
1.3
1.5
—
—
—
0
0
14
112
1.26
0.28
1.4
1.6
—
—
—
0
0
11
85
1.30
0.28
1.2
1.4
—
—
—
0
0
17
140
1.22
0.28
6.1
2.2
180.06
182.93
%
0.06
17
134
5
71
0.70
0.26
1.0
1.1
117.80
119.54
%
—
5
65
12
147
0.81
0.23
1.3
1.8
—
—
—
0
0
15
179
0.83
0.23
1.1
1.1
0.63
0.69
ratio
—
6
19
12
97
1.24
0.23
1.3
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
5
43
1.16
0.21
1.2
1.5
23.20
22.20
nmol/l
—
5
38
11
134
0.82
0.21
3.4
3.1
1.45
1.41
mg/l
0.07
11
120
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
6
49
1.23
0.20
1.3
1.4
—
—
—
0
0
11
90
1.23
0.19
1.4
1.3
—
—
—
0
0
7
62
1.13
0.17
1.3
1.4
—
—
—
0
0
10
82
1.22
0.17
1.2
1.4
—
—
—
0
0
5
67
0.74
0.17
1.4
1.2
—
—
—
0
0
8
72
1.11
0.16
1.5
1.7
—
—
—
0
0
10
84
1.19
0.14
1.5
1.9
—
—
—
0
0
20
180
1.12
0.13
2.0
1.9
—
—
—
0
0
12
106
1.14
0.10
1.4
1.5
91.71
52.55
ug/l
0.70
12
106
5
47
1.06
0.09
1.0
1.1
—
—
—
0
0
16
147
1.09
0.07
6.0
2.0
100.69
91.16
%
1.21
16
142
7
83
0.84
0.07
7.0
2.5
13.23
7.98
pmol/l
—
7
83
12
110
1.09
0.05
1.4
1.5
—
—
—
0
0
97
981
0.99
0.02
2.6
2.3
—
—
—
0
0
34
347
0.98
0.01
3.2
4.9
2.76
8.01
ug/l
2.45
25
283
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
5
54
0.93
-0.00
1.2
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
11.0
—
10.15
—
0
6
0
6
0.00
-0.00
0.0
1.0
—
0.01
—
0
6
0
7
0.00
-0.00
0.0
3.1
—
—
—
0
0
8
87
0.92
-0.00
1.5
1.4
—
—
—
0
0
8
82
0.98
-0.00
1.5
1.8
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
54
0.93
-0.00
1.2
1.4
—
—
—
0
0
9
91
0.99
-0.00
1.2
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
5.98
—
0
6
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
53
0.94
-0.00
1.2
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
—
—
0
0
6
64
0.94
-0.00
6.0
5.0
23.00
77.36
u/ml
—
6
58
7
78
0.90
-0.00
1.3
1.5
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: R18_FASCICULATION – Fasciculation
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).